Ke R, Viswakarma N, Menhart M, Singh S, Kumar S, Srivastava P
Oncogene. 2024; 43(30):2307-2324.
PMID: 38858590
DOI: 10.1038/s41388-024-03055-8.
Nair R, Kumar S, Das S, Singh S, Srivastava P, Sondarva G
Oncogene. 2023; 42(14):1132-1143.
PMID: 36813855
DOI: 10.1038/s41388-023-02633-6.
Pang K, Wang W, Qin J, Shi Z, Hao L, Ma Y
MedComm (2020). 2022; 3(4):e175.
PMID: 36349142
PMC: 9632491.
DOI: 10.1002/mco2.175.
Zhang J, Cai X, Cui W, Wei Z
Genes (Basel). 2022; 13(10).
PMID: 36292671
PMC: 9601900.
DOI: 10.3390/genes13101786.
Kumar S, Das S, Sun J, Huang Y, Singh S, Srivastava P
Proc Natl Acad Sci U S A. 2022; 119(38):e2205454119.
PMID: 36095190
PMC: 9499572.
DOI: 10.1073/pnas.2205454119.
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3.
Singh S, Kumar S, Viswakarma N, Principe D, Das S, Sondarva G
Oncogene. 2021; 40(43):6153-6165.
PMID: 34511598
PMC: 8553609.
DOI: 10.1038/s41388-021-02007-w.
Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development.
Viswakarma N, Sondarva G, Principe D, Nair R, Kumar S, Singh S
Cancer Lett. 2021; 515:1-13.
PMID: 34052323
PMC: 8215900.
DOI: 10.1016/j.canlet.2021.04.015.
Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity.
Kumar S, Singh S, Viswakarma N, Sondarva G, Nair R, Sethupathi P
Proc Natl Acad Sci U S A. 2020; 117(14):7961-7970.
PMID: 32209667
PMC: 7149389.
DOI: 10.1073/pnas.1921325117.
Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas.
He J, Huang Z, He M, Liao J, Zhang Q, Wang S
Mol Cancer. 2020; 19(1):17.
PMID: 31992303
PMC: 6986105.
DOI: 10.1186/s12943-019-1120-1.
Identification of two distinct peptide-binding pockets in the SH3 domain of human mixed-lineage kinase 3.
Kokoszka M, Kall S, Khosla S, McGinnis J, Lavie A, Kay B
J Biol Chem. 2018; 293(35):13553-13565.
PMID: 29980598
PMC: 6120190.
DOI: 10.1074/jbc.RA117.000262.
Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation.
Zhang B, Zhang Z, Wang J, Yang B, Zhao Y, Rao Z
Oncol Lett. 2018; 15(5):7531-7536.
PMID: 29740482
PMC: 5934725.
DOI: 10.3892/ol.2018.8276.
Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines.
Garman B, Anastopoulos I, Krepler C, Brafford P, Sproesser K, Jiang Y
Cell Rep. 2017; 21(7):1936-1952.
PMID: 29141224
PMC: 5709812.
DOI: 10.1016/j.celrep.2017.10.052.
Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
Viswakarma N, Nair R, Sondarva G, Das S, Ibrahimi L, Chen Z
Oncotarget. 2017; 8(20):33172-33184.
PMID: 28388540
PMC: 5464859.
DOI: 10.18632/oncotarget.16566.
MLK3 Signaling in Cancer Invasion.
Rattanasinchai C, Gallo K
Cancers (Basel). 2016; 8(5).
PMID: 27213454
PMC: 4880868.
DOI: 10.3390/cancers8050051.
Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
Das S, Sondarva G, Viswakarma N, Nair R, Osipo C, Tzivion G
J Biol Chem. 2015; 290(35):21705-12.
PMID: 26152725
PMC: 4571892.
DOI: 10.1074/jbc.M115.655563.
MLK3 phophorylates AMPK independently of LKB1.
Luo L, Jiang S, Huang D, Lu N, Luo Z
PLoS One. 2015; 10(4):e0123927.
PMID: 25874865
PMC: 4395454.
DOI: 10.1371/journal.pone.0123927.
Overexpression of C-terminal fragment of glutamate receptor 6 prevents neuronal injury in kainate-induced seizure via disassembly of GluR6-PSD-95-MLK3 signaling module.
Mou J, Liu X, Pei D
Neural Regen Res. 2015; 9(23):2059-65.
PMID: 25657722
PMC: 4316469.
DOI: 10.4103/1673-5374.147932.
Pharmacologic inhibition of MLK3 kinase activity blocks the in vitro migratory capacity of breast cancer cells but has no effect on breast cancer brain metastasis in a mouse xenograft model.
Rhoo K, Granger M, Sur J, Feng C, Gelbard H, Dewhurst S
PLoS One. 2014; 9(9):e108487.
PMID: 25264786
PMC: 4180451.
DOI: 10.1371/journal.pone.0108487.